Investigative clinical therapeutic studies and clinical therapeutic studies in children with acute leukemia, malignant lymphoma, histocytosis X, and malignant solid tumors (brain tumors, neuroblastoma, Wilms' tumor, osteogenic sarcoma, Ewing's sarcoma, soft tissue and miscellaneous malignant neoplasms) are conducted at four levels. 1) Phase I coordinated studies of human pahrmacologic and toxicologic aspects of new anticancer agents and new combination in dosage regimens: 2) Phase II systematic investigations of the effectiveness of individual anticancer agents or treatment program in specific tumors: 3) Phase II comparative evaluations os selected drugs and/or therapy regimes; and 4) Specific laboratory investigations in immunology and laboratory and clinical pharmacology. The functioning cooperative group study mechanism is utilized to increase the size of the study population and to shorten the duration of the study. Members of the project professional personnel participate in the cooperative group study mechanism as study coordinators, intergroup study direction, and scientific program guidance. Independent investigative probes are undertaken to explore leads resulting from or directed towards group studies. Several intergroup and national studies, ongoing and projected (National Wilms' Tumor Study, Intergroup Rhabdmyosarcoma Study, Intergroup Ewing's Sarcoma Study, and Hepatoma Study) are include. Active participation in epidemiological studies is projected. This research will be executed in an integrated multimodel manner. Attention to centralized data management will be given for the individual specialties of pediatrics, surgery, radiotherapy, pathology, and laboratory support. Special attention will be given to current protocols, and protocols to come, employing high dose methotrexate and/or cis-platinum, and protocols requiring classification and pharmacology of lymphoid malignancies, in order to establish proper therapy assignment. The research will be based at M.D. Anderson Hospital as the primary institution and The University of Texas Medical Branch at Galverston as a Satellite.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA003713-31
Application #
3555765
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-01-01
Project End
1990-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
31
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Sullivan, M P; Brecher, M; Ramirez, I et al. (1991) High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. Am J Pediatr Hematol Oncol 13:288-95
Link, M P; Goorin, A M; Horowitz, M et al. (1991) Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res :8-14
Sullivan, M P; Fuller, L M; Berard, C et al. (1991) Comparative effectiveness of two combined modality regimens in the treatment of surgical stage III Hodgkin's disease in children. An 8-year follow-up study by the Pediatric Oncology Group. Am J Pediatr Hematol Oncol 13:450-8
Culbert, S J; Shuster, J J; Land, V J et al. (1991) Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study. Cancer 67:37-42
Cangir, A; Vietti, T J; Gehan, E A et al. (1990) Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 66:887-93
Steuber, C P; Culbert, S J; Ravindranath, Y et al. (1990) Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988). Haematol Blood Transfus 33:198-209
Sullivan, M P; Pullen, D J; Crist, W M et al. (1990) Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials. Leukemia 4:6-11
van Eys, J; Berry, D; Crist, W et al. (1989) A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study. Cancer 63:23-9
Van Eys, J; Berry, D; Crist, W et al. (1989) Treatment intensity and outcome for children with acute lymphocytic leukemia of standard risk. A Pediatric Oncology Group Study. Cancer 63:1466-71
van Eys, J; Berry, D M; Crist, W et al. (1987) Effect of trimethoprim/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia. A Pediatric Oncology Group Study. Cancer 59:19-23

Showing the most recent 10 out of 28 publications